Diagnosis and management of tremor

Archives of Internal Medicine

Volumn 160, Issue 16, 2000, Pages 2438-2444

  Habib ur Rehman, ^a  

^a HULL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALCOHOL; AMANTADINE; ANTIDEPRESSANT AGENT; APOMORPHINE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BOTULINUM TOXIN; CARBIDOPA PLUS LEVODOPA; CHLORDIAZEPOXIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; CLOZAPINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; LEVODOPA; NEUROLEPTIC AGENT; NIPRADILOL; ONDANSETRON; PRIMIDONE; PROPRANOLOL; THEOPHYLLINE; TRIHEXYPHENIDYL; VALPROIC ACID;

BRAIN DEPTH STIMULATION; CLINICAL TRIAL; DISEASE CLASSIFICATION; ESSENTIAL TREMOR; HUMAN; NEUROSURGERY; PALLIDOTOMY; PRIORITY JOURNAL; REVIEW; THALAMOTOMY; THERMOCOAGULATION; TREMOR;

EID: 0034638076     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.16.2438     Document Type: Review

References (96)

1. Consensus statement of Movement Disorder Society on Tremor
2. Visual and mechanical control of postural and kinetic tremor in cerebellar system disorders
3. Primary writing tremor
4. Writing tremor: Its relationship to benign essential tremor
5. Primary writing tremor and myoclonic writer's cramp
6. Primary writing tremor
7. Primary writing tremor
8. The effect of aging upon physiological tremor
9. Essential tremor in Rochester, Minnesota: A 45 year study
10. Essential tremor: A clinical and genetic population study
11. A study of hereditary essential tremor
12. A Study of hereditary essential tremor
13. Orthostatic tremor
14. Primary orthostatic tremor: Further observations in six cases
15. An unusual jaw tremor with characteristics of primary orthostatic tremor
16. Evidence for a non-orthostatic origin of orthostatic tremor
17. Orthostatic tremor: Essential and symptomatic cases
18. Orthostatic tremor: Delayed onset following head trauma
19. Symptomatic orthostatic tremor in pontine lesions
20. New clinical sign for orthostatic tremor
21. Geniospasm: Hereditary chin trembling
22. The nature of primary vocal tremor
23. Clinical aspects of spasmodic dysphonia
24. Essential vocal tremor: Clinical characteristics and response to therapy
25. Pharmacologic treatment of tremor
26. Cervical dystonia (spasmodic torticollis): Some aspects of the natural history
27. Hand tremor in patients with spasmodic torticollis
28. Tremor, the cogwheel phenomenon and clonus in Parkinson's disease
29. Delayed onset of 'rubral tremor' 23 years after brainstem trauma
30. Rest tremor and extrapyramidal symptoms after midbrain haemorrhage: Clinical and 18F-dopa PET evaluation
31. Benign thalamic cyst presenting with contralateral postural tremor
32. Myorhythmia: A widespread movement disorder: Clinicopathological correlations
33. Pathology of symtomatic tremors
34. Symptomatic and essential rhythmic palatal myoclonus
35. Overview of human tremor physiology
36. Palatal tremor, progressive multiple cranial nerve palsies, and cerebellar ataxia: A case report and review of literature of palatal tremors in neurodegenerative disease
37. Tardive tremor
38. X-linked bulbospino-muscular atrophy (Kennedy's disease) masquerading as lead neuropathy
39. Hereditary motor-sensory neuropathy and movement disorders
40. Multifocal motor neuropathy: Response to human immune globulin
41. Charcot-Marie-Tooth disease: Clinical study in 45 patients
42. Recurrent Guillain-Barre syndrome: Clinical and laboratory features
43. HTLV-1 associated neuropathy
44. Tremor associated with benign IgM paraproteinaemic neuropathy
45. Tremor as a feature of chronic relapsing and dysgamma-globulinemic polyneuropathies: Incidence and management
46. Diagnostic criteria and clinical course of psychogenic tremors
47. Classification and treatment of tremor
48. Effect of alcohol on tremor: Comparison to propranolol
49. The effect of ethanol on alcohol-responsive essential tremor: A positron emission tomography study
50. Treatment du tremblement essential familial par le propranolol
51. Essential tremor
52. Treatment of essential and parkinsonian tremor with nipradilol
53. A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor
54. Efficacy of an adenosine antagonist, theophylline, in essential tremor: Comparison with placebo and propranolol
55. Efficacy of primidone in essential tremor
56. Primidone in the long-term treatment of essential tremor: A prospective study with computerized quantitative analysis
57. A double-blind trial of clonazepam in benign essential tremor
58. Acute and chronic effects of clozapine in essential tremor
59. A randomized double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor
60. Botulinum toxin treatment of essential head tremor
61. Treatment of speech and voice disorders with botulinum toxin
62. Pharmacologic treatment of parkinsonian tremor
63. Reduction of parkinsonian signs in patients with Parkinson's disease by dopaminergic versus anti-cholinergic single-dose challenges
64. Bromocriptine and levodropa (with or without cardidopa) in parkinsonism
65. The antiparkinsonian efficacy of bromocriptine
66. Lisuride in parkinsonian
67. Lisuride in parkinsonism
68. Adjuvant therapy of parkinsonian tremor
69. Apomorphine in the diagnosis and treatment of parkinsonian tremor
70. Clozapine in the treatment of tremor
71. Benztropine versus clozapine for the treatment of tremor in Parkinson's disease
72. Clozapine in Parkinson's disease: Effects of acute and chronic administration
73. Orthostatic tremor: Combined treatment with primidone and clonazepam
74. Orthostatic tremor (shaky legs syndrome)
75. Orthostatic tremor: Clinical and electrophysiologic characteristics
76. Levodopa may improve orthostatic tremor: Case report and trial of treatment
77. Effective treatment of orthostatic tremor with gabapentin
78. Gabapentin in orthostatic tremor: Results of a double-blind crossover with placebo in four patients
79. Trunk and head tremor in isolated manifestations of dystonia
80. Clonazepam-sensitive intermittent dystonic tremor
81. Uncommon forms of tremor
82. Successful treatment of two cases of intention tremor with clonazepam
83. Odansetron, a 5-HT3 antagonist, improves cerebellar tremor
84. Suppression of 'rubral' tremor with levodopa
85. Posttraumatic tremor
86. Hereditary motor-sensory neuropathy and movement disorders
87. The longterm results of stereotaxic surgery and L-dopa therapy in patients with Parkinson's disease
88. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor
89. High-frequency unilateral thalamic stimulator in the treatment of essential and parkinsonian tremor
90. Multicentre European study of thalamic stimulation in parkinsonian and essential tremor
91. Pallidotomy for Parkinson's disease
92. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease
93. Stimulation of subthalamic nucleus alleviates tremor in Parkinson's disease
94. Stereotaxic operation in cases of hereditary and intention tremor
95. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders
96. Primary writing tremor treated by stereotactic selective thalamotomy